Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,506 $ 527
Accounts receivable, net 23,892 21,155
Inventories, net 6,095 6,528
Other current assets 3,829 3,955
Total current assets 35,322 32,165
Medical equipment for sale or rental 2,763 3,157
Medical equipment in rental service, net of accumulated depreciation 38,615 39,175
Property & equipment, net of accumulated depreciation 3,922 4,030
Goodwill 3,710 3,710
Intangible assets, net 6,208 6,456
Operating lease right of use assets 5,244 5,374
Deferred income taxes 6,749 7,188
Derivative financial instruments 1,152 1,481
Other assets 597 878
Total assets 104,282 103,614
Current liabilities:    
Accounts payable 8,367 9,848
Other current liabilities 7,602 7,813
Total current liabilities 15,969 17,661
Long-term debt 28,707 23,864
Operating lease liabilities, net of current portion 4,458 4,560
Total liabilities 49,134 46,085
Stockholders’ equity:    
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued 0 0
Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,973,616 shares issued and outstanding as of March 31, 2025 and 21,272,351 shares issued and outstanding as of December 31, 2024 2 2
Additional paid-in capital 114,898 113,868
Accumulated other comprehensive income 870 1,119
Retained deficit (60,622) (57,460)
Total stockholders’ equity 55,148 57,529
Total liabilities and stockholders’ equity $ 104,282 $ 103,614